Lotus Health Group Stock Hits Day Low Amid Price Pressure at CNY 10.68

Lotus Health Group Co., a large-cap player in the FMCG sector, experienced a notable decline today, with its stock price dropping by 7.75% on May 28, 2026. The stock reached an intraday low of CNY 10.68, reflecting a challenging trading session. Despite this downturn, the company has shown resilience over a longer time frame, with a year-to-date performance of 83.11%, significantly outperforming the China Shanghai Composite, which stands at 3.27%. Over the past year, however, Lotus Health Group has underperformed the broader market, generating negative returns of 17.89% compared to the composite's 22.72% gain. Key financial metrics indicate a return on equity (ROE) of 14.42% and a price-to-book ratio of 5.81, suggesting a relatively expensive valuation. The company's inventory turnover ratio is at its lowest, recorded at 13.53 times, while profits have increased by 44.4% despite the stock's recent struggles. As the market continues to evolve, Lotus Health Group's performance will be closely monitored for any shifts in its operational dynamics.